Our partners



HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines. The company has a solid international presence in more than 39 countries, with its own subsidiaries and production plants strategically located in Europe and America. Nowadays, HIPRA is developing a Covid-19 vaccine based on a recombinant protein. It is expected that the vaccine will be available in the first half of 2022. 



IrsiCaixa is an international landmark centre for research, primarily into the eradication of HIV/AIDS and related diseases. With a broad expertise in the immune system, IrsiCaixa also tackles other biomedical challenges, such as those associated with the microbiome and emerging infectious diseases.


Veristat is a scientific-minded CRO with a worldwide presence focused on therapeutic development in North America, Europe, and Asia/Pacific. Veristat supports regulatory strategy, clinical trial design and implementation, data analysis, preparation of marketing applications, and post-marketing pharmacovigilance. We have assembled an extraordinary team of experts who specialize in supporting biopharma in developing the most complex, novel, rare, and advanced therapies. Veristat supported clients in preparing marketing applications for 12% of the 2021 U.S. Food and Drug Administration (FDA) novel drug ap-provals.



Vall d’Hebron Institute of Research is an institution that promotes, develops and transfers research of the Vall d’Hebron University Hospital. Through international leadership and excellence in our research, we improve people’s health and quality of life.



Penta is an international independent research network dedicated to scientific research in favor of children’s health. Through collaborations between clinicians and researchers in 110+ centres in 31 countries, we have brought infectious diseases and the issue of antimicrobial resistance to the fore given their threat to global public health.



FLS is a non-profit organization dedicated to clinical research in the field of infectious diseases. Created in 1992 by Dr. BonaventuraClotet, the FLS is the Infectious Diseases Service of the Germans Trias Hospital, a public hospital located in Badalona that belongs to the network of the Catalan Institute of Health, popularly known as Can Ruti.

European Aids Treatment Group


The European AIDS Treatment Group (EATG) is a patient-led NGO. Since 1992, we advocate for the rights and interests of people living with or affected by HIV/ AIDS and related co-infections within the WHO Europe region. EATG represents the diversity of more than 2,3 million people living with HIV in Europe and their communities.



The August Pi i Sunyer Biomedical Research Institute (IDIBAPS) is a biomedical research centre of excellence that addresses the most common diseases in our environment.  IDIBAPS focuses on ensuring that the questions that arise at the patient’s bedside have a response in the laboratory, and that advances made in the laboratory are promptly applied to patients.



METPHARM R&D provides strategical and operational project management in market access, clinical research, HEOR, regulatory and medical affairs. Builds and coordinates top quality expert teams tailored for the projects.  Helps to drive healthcare forward by creating right connections with an expansive portfolio of capabilities and expertise.



The Girona Biomedical Research Institute (IDIBGI) is a CERCA research centre of the Generalitat de Catalunya (Spain) whose purpose is to promote, develop, transfer, manage and disseminate biomedical research, scientific and technological knowledge, teaching and training in the areas of life and health sciences.



Asphalion is an International Drug Development and Regulatory Affairs Consultancy based in Barcelona, with over 1,800 accumulated projects, and activity in over 50 countries.


Vinces Consulting

Vinces is a strategic consulting firm in corporate and government affairs that works with an integrated methodology to build the social legitimacy of our clients.  Our mission is to contribute to improve the relationship between the private and public spheres, helping actors from both sides to participate in public affairs under a new paradigm.

Zabala Innovation

Zabala Innovation

Zabala Innovation brings together (370+) experienced advisors located internationally across multiple offices specialised in assisting clients with access to grant funding from several European and International authorities.